American College of Cardiology, March 28-30

Follow Drugslib on

By Physician’s Briefing Staff HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

The annual meeting of the American College of Cardiology was held from March 28 to 30 in New Orleans and attracted participants from around the world, including clinicians, academicians, allied health professionals, and others interested in cardiology. The conference highlighted recent advances in the treatment, management, and prevention of cardiovascular diseases, with presentations focusing on novel drugs and surgical approaches to improve the quality of care for patients with cardiovascular diseases.

ACC: Percutaneous Coronary Intervention Can Be Delayed Until After TAVR in Some Patients

FRIDAY, April 3, 2026 -- Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement have comparable outcomes regardless of whether they undergo percutaneous coronary intervention before valve replacement, according to a study presented at the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans.

Read Full Text

ACC: DASH Diet Grocery Delivery Program Aids Blood Pressure, Cholesterol

FRIDAY, April 3, 2026 -- Black adults with high blood pressure who receive dietitian counseling and home deliveries of groceries aligned with the Dietary Approaches to Stop Hypertension diet experience improvements in blood pressure at three months, according to a study published online March 28 in Nature Medicine to coincide with the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans.

Read Full Text

ACC: Discontinuing β-Blockers Noninferior for Stabilized Acute MI

THUSDAY, April 2, 2026 -- For stabilized acute myocardial infarction without left ventricular systolic dysfunction or heart failure, discontinuing β-blockers after one year or longer is noninferior to continuing β-blockers, according to a study published online March 30 in the New England Journal of Medicine to coincide with the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans.

Read Full Text

ACC: Intensive LDL Cholesterol Targeting Beneficial for Patients With Atherosclerotic CVD

THURSDAY, April 2, 2026 -- For patients with atherosclerotic cardiovascular disease, targeting a low-density lipoprotein cholesterol level of <55 mg/dL results in a lower risk for cardiovascular events, according to a study published online March 28 in the New England Journal of Medicine to coincide with the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans.

Read Full Text

ACC: Catheter-Directed Fibrinolysis Added to Anticoagulation Improves Pulmonary Embolism Outcomes

THURSDAY, April 2, 2026 -- Outcomes for acute, intermediate-risk pulmonary embolism are better with ultrasound-facilitated, catheter-directed fibrinolysis plus anticoagulation versus anticoagulation alone, according to a study published March 28 in the New England Journal of Medicine to coincide with the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans.

Read Full Text

ACC: Expanding Eligibility for Low-Income Subsidies Can Improve CVD Medication Adherence

WEDNESDAY, April 1, 2026 -- Expanding eligibility for full low-income subsidies to include those with incomes between 135 and 150 percent of the federal poverty level is associated with a reduction in cost-related medication nonadherence in Medicare beneficiaries with cardiovascular disease or major cardiovascular risk factors. The research was published online March 24 in the Journal of the American College of Cardiology to coincide with the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans.

Read Full Text

ACC: Mavacamten Efficacious for Adolescents With Obstructive Hypertrophic Cardiomyopathy

WEDNESDAY, April 1, 2026 -- Mavacamten, the first-in-class cardiac myosin inhibitor approved for treatment of symptomatic adults with obstructive hypertrophic cardiomyopathy (HCM), is efficacious for adolescents with obstructive HCM, according to a study published online March 29 in the New England Journal of Medicine to coincide with the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans.

Read Full Text

ACC: Cold Weather Has Greater Impact on Cardiac Mortality Than Excessive Heat

WEDNESDAY, April 1, 2026 -- Colder temperatures are linked to significantly more cardiovascular deaths than excessive heat, according to a short report published online March 24 in the American Journal of Preventive Cardiology to coincide with the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans.

Read Full Text

ACC: Alcohol's Health Impacts Depend on Type, Quantity of Drink Consumed

MONDAY, March 30, 2026 -- The potential health impacts of low-to-moderate alcohol intake appear to vary by beverage type, according to a study presented at the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans.

Read Full Text

ACC: Hypertensive Heart Disease Mortality Increasing in Young Women

FRIDAY, March 20, 2026 -- Since 1999, there has been an increase in hypertensive heart disease mortality among young women, according to a study presented at the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans.

Read Full Text

ACC: Early Morning Best Time to Exercise for Cardiometabolic Risk Reduction

THURSDAY, March 19, 2026 -- Exercise in the early morning, compared with later in the day, appears to be associated with a greater reduction in cardiometabolic risks, according to a study presented at the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans.

Read Full Text

ACC: Higher Ultraprocessed Food Consumption Tied to Increased Risk for Atherosclerotic CVD

THURSDAY, March 19, 2026 -- Higher consumption of ultraprocessed food is associated with an increased risk for atherosclerotic cardiovascular disease events, according to a study published online March 17 in JACC Advances to coincide with the annual meeting of the American College of Cardiology, being held from March 28 to 30 in New Orleans.

Read Full Text

ACC: Shingles Vaccine May Lower Risk for MACE in Patients With Atherosclerotic CVD

THURSDAY, March 19, 2026 -- For adults aged 50 years and older with a diagnosis of atherosclerotic cardiovascular disease, herpes zoster vaccination is associated with a lower risk for major adverse cardiovascular events and secondary cardiovascular outcomes, according to a study scheduled for presentation at the annual meeting of the American College of Cardiology, being held from March 28 to 30 in New Orleans.

Read Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-08 09:03

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords